Literature DB >> 23179318

Subsequent gene expression pattern in dendritic cells following multiple trauma.

Emanuel V Geiger1, Marcus Maier, Serin Schiessling, Sebastian Wutzler, Mark Lehnert, Ingo Marzi, Dirk Henrich.   

Abstract

PURPOSE: Major trauma initiates a systemic inflammatory response, which is characterized by systemic release of various chemokines. There is growing evidence for the extraordinary role of dendritic cells (DC) as professional antigen-presenting cells and activators of the immune response. Recently, the impact of severe trauma on DC transcriptomic activation was demonstrated. The purpose of the present study was to evaluate gene expression pattern in DC following multiple trauma to gain further understanding of the mechanisms of posttraumatic immune response.
METHODS: Ten patients with multiple injuries aged 20 to 46 years (mean 30 ± 9.2 years) were included in this study. The mean injury severity score (ISS) was 36 ± 10.4 points. Repeated blood samples were taken on the day of admission (day 0) and on five consecutive days (day 1 to day 5). Microarray analysis and RT-qPCR were performed in primary isolated DC.
RESULTS: A mean of 116,000 ± 21,466 DC with a purity of 96 ± 0,8 % were harvested. Gene expression of CCL5 and CXCL5 as well as TIMP1 and GUCY1B3 showed a significant increase within the first 4 days after trauma. The time-dependent increase of these genes correlated significantly with serum CRP concentration and the total number of DC but neither with age nor with injury severity.
CONCLUSIONS: Our study provides new data regarding temporal expression patterns of CCL5, CXCL5, TIMP1, and GUCY13B in multiple trauma. DC activation following trauma may follow a uniform pattern early after admission, eventually leading to cell recruitment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179318     DOI: 10.1007/s00423-012-1031-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  24 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 2.  Controlling the Toll road to dendritic cell polarization.

Authors:  Alessandra Mazzoni; David M Segal
Journal:  J Leukoc Biol       Date:  2004-01-14       Impact factor: 4.962

3.  Altered gene expression patterns in dendritic cells after severe trauma: implications for systemic inflammation and organ injury.

Authors:  Marcus Maier; Sebastian Wutzler; Michael Bauer; Petar Trendafilov; Dirk Henrich; Ingo Marzi
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

4.  Characteristics of polytrauma patients between 1992 and 2002: what is changing?

Authors:  S Aldrian; F Koenig; P Weninger; V Vécsei; T Nau
Journal:  Injury       Date:  2007-08-15       Impact factor: 2.586

Review 5.  Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.

Authors:  Nathalie Cools; Peter Ponsaerts; Viggo F I Van Tendeloo; Zwi N Berneman
Journal:  J Leukoc Biol       Date:  2007-08-21       Impact factor: 4.962

6.  Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.

Authors:  Xu-Wen Liu; Marcus E Taube; Ki-Kyung Jung; Zhong Dong; Yong J Lee; Stefanie Roshy; Bonnie F Sloane; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

7.  Local and systemic chemokine patterns in a human musculoskeletal trauma model.

Authors:  Daniel Bastian; Margareth Vislie Tamburstuen; Ståle Petter Lyngstadaas; Olav Reikerås
Journal:  Inflamm Res       Date:  2009-03-10       Impact factor: 4.575

8.  Platelet factor 4 is highly upregulated in dendritic cells after severe trauma.

Authors:  Marcus Maier; Emanuel V Geiger; Dirk Henrich; Carolyn Bendt; Sebastian Wutzler; Mark Lehnert; Ingo Marzi
Journal:  Mol Med       Date:  2009-08-27       Impact factor: 6.354

9.  Significant decline of peripheral myeloid dendritic cells following multiple trauma.

Authors:  Dirk Henrich; Marcus Maier; Borna Relja; Petar Trendafilov; Serin Schiessling; Manuela Wirth; Thorsten Ottilinger; Ann-Kathrin Nielsen; Hendrik Wyen; Ingo Marzi
Journal:  J Surg Res       Date:  2008-08-26       Impact factor: 2.192

Review 10.  Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

Authors:  William G Stetler-Stevenson
Journal:  Sci Signal       Date:  2008-07-08       Impact factor: 8.192

View more
  4 in total

1.  Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury.

Authors:  Yuwen Chen; Ying Wang; Jian Xu; Tingting Hou; Jing Zhu; Yingzi Jiang; Liying Sun; Chunling Huang; Lulu Sun; Su Liu
Journal:  Inflammation       Date:  2022-08-15       Impact factor: 4.657

2.  Toll-Like Receptor 4 on both Myeloid Cells and Dendritic Cells Is Required for Systemic Inflammation and Organ Damage after Hemorrhagic Shock with Tissue Trauma in Mice.

Authors:  Kent Zettel; Sebastian Korff; Ruben Zamora; Adrian E Morelli; Sophie Darwiche; Patricia A Loughran; Greg Elson; Limin Shang; Susana Salgado-Pires; Melanie J Scott; Yoram Vodovotz; Timothy R Billiar
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

3.  Epigenetics in critical illness: a new frontier.

Authors:  Brian T Graves; Cindy L Munro
Journal:  Nurs Res Pract       Date:  2013-07-09

Review 4.  Sterile post-traumatic immunosuppression.

Authors:  Md Nahidul Islam; Benjamin A Bradley; Rhodri Ceredig
Journal:  Clin Transl Immunology       Date:  2016-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.